Liraglutide In a study with 2,000 adults diagnosed with obesity using semaglutide, about half of patients lost 15% of their body weight over 68 weeks
It also acts on specific areas of the brain that control appetite and food cravings, making it easier to maintain a reduced-calorie diet
Clinical trial data shows that if youve lost at least 5% of your starting body weight by week 12, there is an 87% probability youll achieve 15% or more by week 48
Another retrospective study shows that semaglutide is associated with a greater reduction in alcohol hospitalization (36%) than currently approved medications for AUD and is also associated with fewer somatic hospitalizations
ACS Symposium Series (2024) 1465:342
Tirzepatide has rigorous Phase 3 randomized controlled trial data demonstrating consistent weight loss, improved HbA1c, and durable effects across diverse populations